EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSACLG00000002525
Gene Symbol: KIF5B
4 Cross references
245 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSACLG00000005775
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSACLG00000001628
Gene Symbol: LOC113019188
3 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSACLG00000005303
Gene Symbol: LOC113011171
3 Cross references
154 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSACLG00000001641
Gene Symbol: LOC113019191
3 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSACLG00000005311
Gene Symbol: LOC113011377
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSACLG00000005295
Gene Symbol: LTB4R2B
1 Cross references
158 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSACLG00000015092
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSACLG00000010723
Gene Symbol: LOXL2A
1 Cross references
208 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSACLG00000004817
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSACLG00000013343
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSACLG00000021639
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).